Shanghai Kaibao Pharmaceutical Co Ltd 300039-CN:Shenzhen Stock Exchange

*Data is delayed | Exchange | CNY
Last | 1:29 PM CTT
6.01quote price arrow up+0.07 (+1.18%)
Volume
8,895,629
52 week range
5.25 - 8.58
Loading...
  • Open5.94
  • Day High6.05
  • Day Low5.92
  • Prev Close5.94
  • 52 Week High8.58
  • 52 Week High Date04/27/23
  • 52 Week Low5.25
  • 52 Week Low Date02/05/24

Key Stats

  • Market Cap832.05M
  • Shares Out1,046M
  • 10 Day Average Volume-
  • Dividend0.06
  • Dividend Yield1.00%
  • Beta-
  • YTD % Change-

KEY STATS

  • Open5.94
  • Day High6.05
  • Day Low5.92
  • Prev Close5.94
  • 52 Week High8.58
  • 52 Week High Date04/27/23
  • 52 Week Low5.25
  • 52 Week Low Date02/05/24
  • Market Cap832.05M
  • Shares Out1,046M
  • 10 Day Average Volume-
  • Dividend0.06
  • Dividend Yield1.00%
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)0.26
  • P/E (TTM)23.42
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Shanghai Kaibao Pharmaceutical Co Ltd

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Shanghai Kaibao Pharmaceutical CO.,Ltd. is a China-based company principally engaged in the research, development, manufacture and distribution of Chinese patent drugs. The Company's main product is Tanreqing injection, which is used for treatment of upper respiratory tract infections, such as cold and pneumonia. The Company's products include injections, tablets, capsules, granules, vinum and pills, among others. The Company distributes its products in domestic markets.
Jingwei Mu
Chairman of the Board
Liwang Ren
Chief Financial Officer, Secretary of the Board, Director
Address
No. 88
Chengpu Road
Industrial Comprehensive Development Zne
Shanghai, SHA
201401
China